Assist Prof Dr. Em-on Chaiprateep | Healthcare Applications | Best Researcher Award

Assist Prof Dr. Em-on Chaiprateep | Healthcare Applications | Best Researcher Award

Em-on Chaiprateep at Faculty of Integrative Medicine, Thailand

Profiles

Orcid

Google Scholar

📚 Summary

Dr. Em-on Chaiprateep is an Assistant Professor at the Faculty of Integrative Medicine, Rajamangala University of Technology Thanyaburi, Thailand. With extensive experience in pharmaceutical sciences, clinical research, and regulatory affairs, her expertise spans dermal drug delivery, traditional medicine, and integrative healthcare. She has contributed significantly to academia through teaching, research, and leadership roles.

Education

  • Doctor of Philosophy (Ph.D.) – Philipps-Universität Marburg, Germany (2021–present)
    Research: Essential influences on dermal penetration efficacy of active compounds
  • Master’s in Pharmacy, Food Chemistry & Medical Nutrition – Chulalongkorn University, Thailand (2008–2011)
  • Bachelor’s in Pharmacy, Pharmaceutical Clinic – Silpakorn University, Thailand (2002–2006)

👩‍🏫 Work Experience

  • Rajamangala University of Technology Thanyaburi (2015–Present)
    • Assistant to the Dean for Research (2024–Present)
    • Assistant Professor, Faculty of Integrative Medicine (2018–Present)
    • Lecturer, Faculty of Integrative Medicine (2015–2018)
    • Head of Regulatory Affairs Pharmacist (Traditional Medicine)
  • Eastern Asia University (2011–2014) – Lecturer, Assistant to the Dean for Academic Affairs
  • Ramathibodi Hospital (2008–2011, 2006–2007) – Research Assistant in clinical trials
  • Phyathai II Hospital (2007–2008) – Hospital Pharmacist

🔬 Research Interests

  • Dermal drug delivery and penetration efficacy
  • Traditional and integrative medicine
  • Pharmaceutical formulation and regulatory affairs
  • Patient counseling and medication compliance

💡Skills

  • Technical Skills: SPSS, Epi-data, PowerPoint, Excel, Word
  • Research & Data Analysis: Clinical trials, pharmaceutical formulation, statistical analysis
  • Regulatory Affairs: Traditional medicine, pharmaceutical compliance
  • Teaching & Mentorship: Pharmacy education, student research supervision

 

Publications

Microneedle-Assisted Delivery of Curcumin: Evaluating the Effects of Needle Length and Formulation

  • Authors: Em-on Chaiprateep, Soma Sengupta, Cornelia M Keck
  • Journal: Micromachines
  • Year: 2024

Influence of Dose, Particle Size and Concentration on Dermal Penetration Efficacy of Curcumin

  • Authors: Em-on Chaiprateep, Sabrina Wiemann, Ralph W Eckert, Christian Raab, Soma Sengupta, Cornelia M Keck
  • Journal: Pharmaceutics
  • Year: 2023

Optimization of water-based ultrasonic-microwave assisted extraction (UMAE) of bioactive compounds from Garcinia mangostana pericarp

  • Authors: Juthaporn Kwansang, Chung-Jen Chen, Em-on Chaiprateep
  • Journal: Journal of Complementary and Integrative Medicine
  • Year: 2022

Influence of mechanical skin treatments on dermal penetration efficacy of active ingredients

  • Authors: Cornelia M Keck, Em-on Chaiprateep, Henriette Dietrich, Soma Sengupta
  • Journal: Pharmaceutics
  • Year: 2022

Optimization ultrasonic–microwave-assisted extraction of phenolic compounds from Clinacanthus nutans using response surface methodology

  • Authors: Siriphatr Chamutpong, Chung-Jen Chen, Em-on Chaiprateep
  • Journal: Journal of Advanced Pharmaceutical Technology & Research
  • Year: 2021

Dr. Rainer Hubmann | Biomedical and Healthcare Applications | Best Researcher Award

Dr. Rainer Hubmann | Biomedical and Healthcare Applications | Best Researcher Award

Doctorate at Red Cross | Austria

Mag. Dr. Rainer Hubmann embarked on his academic journey at the University of Vienna, earning his master’s degree in Biology/Genetics in 1996. During this time, he became an active member of the Cell Cycle Club under the leadership of Kim Nasmyth at the Research Institute of Molecular Pathology (IMP). His passion for molecular biology led him to pursue his Ph.D. at the Medical University of Vienna, where he focused on the regulation of CD23 in Chronic Lymphocytic Leukemia (CLL), completing it in 2002.

Professional Profiles

Scopus

Orcid

🎓Education and Academic Background

Dr. Rainer Hubmann’s distinguished academic journey began at the University of Vienna, where he earned a Master’s degree in Biology and Genetics (1987–1996). During this time, he joined the prestigious Cell Cycle Club, led by Kim Nasmyth, sharpening his focus on cell cycle research. He pursued his Ph.D. thesis (1997–2002) at the Medical University of Vienna (MUW), investigating the Regulation of CD23 in Chronic Lymphocytic Leukemia (CLL). His postdoctoral work from 2002 to 2011 extended into pioneering studies on NOTCH2 regulation and the characterization of CLL stem cells. In 2022, he assumed the role of Group Leader and Senior Scientist at the Division of Hematology and Hemostaseology, MUW, further solidifying his leadership in hematological research.

🔬 Research and Innovation

Dr. Hubmann’s research has made groundbreaking strides in NOTCH signaling and its implications in cancer. His work elucidates the central role of NOTCH2 signaling in CLL leukemogenesis, uncovering vital mechanisms of disease progression. He has identified GLIOTOXIN as a potent therapeutic NOTCH2/CSL transactivation inhibitor, presenting it as a promising alternative to conventional γ-secretase inhibitors. Furthermore, he discovered a tumor-suppressor role for NOTCH3 signaling in CLL, revealing its therapeutic potential. Dr. Hubmann’s studies have highlighted the recurring NOTCH2ΔNRR gain-of-function (GOF) mRNA deletions as potentially disease-defining genetic lesions in CLL. His innovative research also explores somatic recombination involving ancient and recent NOTCH2 gene variants, addressing hereditary, geographic, and gender-based variations.

🧪 Patents and Innovations

Dr. Hubmann’s contributions to translational medicine are protected by several patents. These include Gliotoxin for the treatment of NOTCH2-associated malignancies (WO/2006/135949; US Patent No 7,981,878) and NOTCH21A01/1a4-RFLP as a leukemia/tumor predisposition detection tool (MUW Tech-ID: 835.19). His patented innovations underscore his role in translating basic research into clinical applications.

💡 Technical Expertise

Dr. Hubmann possesses advanced technical skills pivotal to hematology and oncology research. His expertise includes gene expression and silencing techniques such as retroviral vectors and siRNA-mediated gene silencing. He is proficient in molecular analysis, including RT-PCR, Northern & Western blotting, and RNA-seq sequence analysis. His work extends to drug screening models, xenograft mouse models, and developing diagnostic tools for personalized medicine. His ability to blend bioinformatics with preclinical studies further enhances his contributions to the field.

💵 Funding and Grants

Over his career, Dr. Hubmann has secured significant funding for his research. Notable grants include FWF P15100 (2001) for studying the Regulation and Function of NOTCH2 in CLL, and ÖNB Jubiläumsfonds (2002, 2004) for exploring NOTCH2 in leukemogenesis. His work on GLIOTOXIN’s therapeutic potential was supported by Initiative Krebsforschung (2013), while his recent studies on NOTCH2ΔNRR deletions were funded by the Fellinger Krebsforschungsfonds (2022). These funding milestones reflect the impact and importance of his research.

🏆 Awards and Recognition

Dr. Hubmann’s outstanding contributions to medical research have earned him numerous accolades. In 1999, he received the Aventis Stiftung Award for his work on fibroblast growth factor in Hairy Cell Leukemia. His innovative findings on interferon-alpha in Hairy Cell Leukemia earned the Erste Bank Preis in 2001. In 2005 and 2010, he was awarded the Sanofi-Aventis Prize for breakthroughs in cancer therapy and PI3-K/Akt/CK2 signaling. Additionally, the Paracelsus Medical University Award (2008) recognized his research on TGF-β in Radon therapy for Ankylosing Spondylitis patients.

🏢 Professional Memberships

Dr. Hubmann is an esteemed member of the Austrian Society for Hematology and Oncology (ÖGHO). He serves as the Vice Coordinator of the Comprehensive Cancer Center Vienna (CCC) Research Cluster, focusing on Microenvironment, Vasculature, and Metastasis, underscoring his leadership in advancing cancer research.

🎓 Teaching and Mentorship

Since 1998, Dr. Hubmann has played a pivotal role in teaching and mentoring young scientists. He leads specialized courses, including Molecular Biology in Hematology-Oncology and Clinical and Experimental Hematology, since 2001. His dedication extends to supervising Ph.D. and diploma students, nurturing the next generation of researchers and clinicians.

Publications Top Noted📚 

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL Cells

Authors: Rainer Hubmann

Journal: Cells

Year: 2020

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

Authors: Rainer Hubmann

Journal: British Journal of Cancer

Year: 2020

Combined approach for characterization and quality assessment of rabbit bone marrow-derived mesenchymal stem cells intended for gene banking

Authors: Rainer Hubmann

Journal: New Biotechnology

Year: 2020

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Authors: Rainer Hubmann

Journal: Nature Chemical Biology

Year: 2019

Critical assessment of the efficiency of CD34 and CD133 antibodies for enrichment of rabbit hematopoietic stem cells

Authors: Rainer Hubmann

Journal: Biotechnology Progress

Year: 2018

Dr. Khadijah Dashti | Biomedical and Healthcare Applications | Best Researcher Award

Dr. Khadijah Dashti | Biomedical and Healthcare Applications | Best Researcher Award

Doctorate at Kuwait University | Kuwait

Dr. Khadijah Mohammed Dashti is a distinguished academic and researcher in the field of Medical Microbiology and Antimicrobial Agents. She currently serves as an Assistant Professor at the Faculty of Allied Health Sciences, Kuwait University, where she has been a faculty member since 2023. With extensive expertise in microbial diseases and innovative approaches to antibiotic discovery, Dr. Dashti is a leading figure in her field.

Professional Profile

Scopus

🎓Academic Qualifications 

Dr. Khadijah Mohammed Dashti holds a rich academic background in Medical Laboratory Sciences and Biomedical Sciences. She completed her Bachelor’s Degree (B.Sc.) in Medical Laboratory Sciences at Kuwait University in 2011, where her research project investigated “The prevalence of plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli in Kuwait.”Her academic journey continued with two Master’s Degrees (M.Sc.). The first, in Biomedical Sciences, was awarded by the University of Westminster in 2015, with her thesis focusing on “The effect of heavy metals on biofilm formed by Pseudomonas aeruginosa.” The second, in Medical Laboratory Sciences, was earned at Kuwait University in 2016, and her thesis explored “The Prevalence of Multidrug-resistant Acinetobacter baumannii in Kuwait and Typing of the Isolates by MLST.”

Dr. Dashti achieved her Ph.D. in Microbial Diseases and Antimicrobial Agents from University College London in 2023. Her doctoral research, titled “Natural Antibiotic Discovery,” reflects her profound dedication to finding innovative solutions to combat antimicrobial resistance.

🧪Academic Experience and Achievements 

Dr. Dashti has been actively involved in academic mentorship, having supervised four B.Sc. student projects since 2023. These projects explored diverse topics such as the antibacterial potential of colistin-resistant Escherichia coli, the use of garlic and essential oils in combating resistance, and the discovery of novel antibacterials by mining Pseudomonas aeruginosa genomes. Her guidance and expertise have fostered critical research in microbial sciences.She has also attended and benefited from workshops such as the Bioinformatics course and the How to Write a Good Dissertation/Thesis session, both presented by Prof. Sebastian Amyes at Kuwait University, further enhancing her academic and mentorship capabilities.

🔬Research Interests 

Dr. Dashti’s research interests center on understanding and combating pathogenic microorganisms and antibiotic resistance. She investigates the mechanisms of drug resistance in critical pathogens such as Staphylococci/MRSA and ESKAPE pathogens, aiming to develop novel antibacterial methods. Her work also delves into understanding host-bacteria interactions, focusing on their dynamics in health and disease. A key area of her current research is the identification of new sources of antibiotic-producing bacteria to address global challenges in infectious disease treatment.

🌍Memberships and Affiliations 

A dedicated professional, Dr. Dashti is an active member of the Society for Applied Microbiology (SfAM) and the Microbiology Society, maintaining her affiliation with both organizations since 2016.

🧠Skills and Expertise 

Dr. Dashti possesses advanced skills in bioinformatics, antimicrobial resistance, and microbial pathogenicity. Her strong expertise in antibiotic discovery and development of novel antibacterial techniques underscores her commitment to addressing infectious diseases. Furthermore, her proficiency in academic supervision, research project guidance, and publication of high-quality research demonstrates her multifaceted expertise in microbial sciences.Dr. Khadijah Mohammed Dashti’s significant contributions to antimicrobial research and her dedication to mentoring future scientists make her an inspiring figure in the field of microbiology.

Publications Top Noted📚

Genetic landscape and clinical outcomes of autosomal recessive polycystic kidney disease in Kuwait

Authors: Alhaddad, M.E., Mohammad, A., Dashti, K.M., Al-Ali, M., Ali, H.
Journal: Heliyon
Year: 2024

Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait

Authors: Vali, L., Dashti, K., Opazo-Capurro, A.F., Al Obaid, K., Evans, B.A.
Journal: Frontiers in Microbiology
Year: 2015

Mrs. Mădălina Țicolea | Healthcare Applications | Best Researcher Award

Mrs. Mădălina Țicolea | Healthcare Applications | Best Researcher Award

Mădălina Țicolea at Iuliu Hațieganu University of Medicine and Pharmacy, Romania

Profiles

Google Scholar

Research Gate

📚 Summary

Mrs. Mădălina Țicolea, Assistant Lecturer and PhD student at Iuliu Hațieganu University, excels in Pathophysiology with a focus on dietary supplements and renal conditions. Her work combines teaching and cutting-edge research, aiming to impact healthcare significantly.

Education

  • B.Sc. in Medicine (2019): Thesis on Hypericum capitatum extract and inflammation.
  • M.Sc. in Nutrition and Lifestyle (2022): Thesis on dietary aspects in Chronic Kidney Disease.
  • Currently Pursuing PhD: Research on dietary supplements and renal pathologies.

💼 Professional Experience

  • University Assistant at Pathophysiology Discipline, teaching and organizing practical activities (Feb 2023–Present).
  • Medic Rezident Nefrolog at Iuliu Hațieganu University, specializing in nephrology and urinary system imaging (2020–Present).
  • Assistant Universitar at the Department of Pathophysiology, focusing on oxidative stress and experimental research (2021–Present).

🔬 Research Interests

Mrs. Mădălina’s research investigates the role of dietary supplements in managing glomerulopathies and inflammation. She employs murine models to explore the impact of these supplements on acute and chronic renal conditions

 

Publications

Phytochemical Profile and Antidiabetic, Antioxidant, and Anti-Inflammatory Activities of Gypsophila paniculata Ethanol Extract in Rat Streptozotocin-Induced Diabetes Mellitus

  • Authors: Lia-Oxana Usatiuc, Marcel Pârvu, Raluca Maria Pop, Ana Uifălean, Dan Vălean, Csilla-Eniko Szabo, Mădălina Țicolea, Florinela Adriana Cătoi, Floricuța Ranga, Alina Elena Pârvu
  • Journal: Antioxidants
  • Year: 2024

Phytochemical Composition Antioxidant and Anti-Inflammatory Activity of Artemisia dracunculus and Artemisia abrotanum

  • Authors: Mădălina Țicolea, Raluca Maria Pop, Marcel Pârvu, Lia-Oxana Usatiuc, Ana Uifălean, Floricuța Ranga, Alina Elena Pârvu
  • Journal: Antioxidants
  • Year: 2024

Brown Tumors: The Hidden Face of Primary and Renal Hyperparathyroidism Amid Real-Life Settings

  • Authors: Mara Carsote, Mihai-Lucian Ciobica, Oana-Claudia Sima, Ana Valea, Cosmina Ioana Bondor, Andreea Geleriu, Madalina Ticolea, Claudiu Nistor, Crina Claudia Rusu
  • Journal: Journal of Clinical Medicine
  • Year: 2024

Triiodothyronine and Protein Malnutrition Could Influence Pulse Wave Velocity in Pre-Dialysis Chronic Kidney Disease Patients

  • Authors: Crina Claudia Rusu, Ina Kacso, Diana Moldovan, Alina Potra, Dacian Tirinescu, Maria Ticala, Ancuta M Rotar, Remus Orasan, Cristian Budurea, Andrada Barar, Florin Anton, Ana Valea, Cosmina Ioana Bondor, Madalina Ticolea
  • Journal: Diagnostics
  • Year: 2023

Remarkable rutin-rich Hypericum capitatum extract exhibits anti-inflammatory effects on turpentine oil-induced inflammation in rats

  • Authors: Anca D Farcas, Augustin C Mot, Cezara Zagrean-Tuza, Madalina Ticolea, Bogdan Sevastre, Muhittin Kulak, Radu Silaghi-Dumitrescu, Alina Parvu
  • Journal: BMC complementary and alternative medicine
  • Year: 2019

Mr. Ardak Kanagatovich Syzdykov | Healthcare Applications | Young Scientist Award

Mr. Ardak Kanagatovich Syzdykov | Healthcare Applications | Young Scientist Award

Ardak Kanagatovich Syzdykov at Institute of Organic Synthesis and Coal Chemistry, Kazakhstan 

Profile

Orcid

Academic Background

Mr. Ardak Kanagatovich Syzdykov is a dedicated and skilled chemical analyst and pharmacist. With a background in chemical technology and pharmacy, he is known for his strong work ethic, quick learning abilities, and effective communication skills. Ardak is highly motivated and committed to making significant contributions in his professional field.

Education

Mr. Ardak’s educational journey began at Ustobin Secondary School (2003-2014), followed by a degree in Pharmacy from Bolashak Higher Academy (2014-2019). He further advanced his expertise with a Master’s Degree in Chemical Technology of Organic Substances from Karaganda Technical University (2019-2021).

Professional Experience

Mr. Ardak has garnered valuable experience through various roles: Chemical Analyst at International Scientific and Production Holding “Fitokhimiya,” Laboratory Assistant Trainee at LLP “Natiyezh,” Pharmacist at LLP “Darysyn,” and Chemical Analyst at LLP “Pharmacy 2010.” His diverse experience underscores his expertise and adaptability in the field.

🛠️ Skills and Competencies

Mr. Ardak is proficient in using MS Office, email, internet browsers, and graphic programs. He excels in rapid information search on the internet and is fluent in Kazakh and Russian, with an A2 level in English. His personal traits include being a team player, quick learner, communicative, responsible, and conflict-free.

 Publications

Synthesis and Biological Activity of New Hydrazones Based on N-Aminomorpholine
  • Authors:Oralgazy Nurkenov, Saule B. Zhautikova, Andrei Khlebnikov, Ардақ Сыздықов, Serik D. Fazylov, Tulegen Seilkhanov, Saule K. Kabieva, Kobylandy M. Turdybekov, Anel Mendibayeva, Gaziza M. Zhumanazarova
  • Journal: Molecules
  • Year: 2024

Dr. Weijian Ye | Biomedical | Best Researcher Award

Dr. Weijian Ye, Biomedical, Best Researcher Award

Doctorate at The First Affiliated Hospital of Jinan University, China

Professional Profile

Summary:

Dr. Weijian YE is a distinguished researcher in the field of Chemical Genomics, with a Ph.D. from Peking University and a Bachelor’s degree from Guangzhou University of Chinese Medicine. With a strong background in Pharmaceutical Engineering, Dr. YE has made significant contributions to biomedical research, particularly in the development of PET tracers and radio pharmacy.

👩‍🎓Education:

  • Ph.D. in Chemical Genomics (Advisor: Prof. LEE, Chi-Sing)
    Peking University, Beijing, China
    Sep. 2014 – Jun. 2019
  • Bachelor’s Degree in Pharmaceutical Engineering (Advisor: Prof. WANG, Tao)
    Guangzhou University of Chinese Medicine, Guangzhou, China
    Sep. 2010 – Jun. 2014

🧬 Work Experience:

Senior Research Fellow
Center of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, Guangzhou
Sep. 2021 – Present

  • Leading research in radio synthesis, PET tracer development, translational medicine, and clinical research.
  • Developing synthetic routes for complex molecules and managing radiopharmaceutical projects from development to cGMP production.
  • Collaborating with departments for clinical research on novel PET tracers for neurological disorders and other diseases.

Post-doctoral Research Fellow (Supervisor: Prof. XU, Hao)
Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, Guangzhou
Jul. 2019 – Jul. 2021

  • Trained in radiochemistry, focusing on synthesizing and managing radioisotopes for pharmaceutical quality and safety.
  • Applied research in clinical translational medicine, bridging lab work to clinical applications.

🔬 Research Experience

 A.Development of PET Tracers/Radio Pharmacy
  1. Norepinephrine Transporter Targeted Tracer 18F-mFBG
    • Optimized labeling conditions, achieving a 17.8% radiochemical yield and >97% radiochemical purity within 70 mins.
    • Established SOP for clinical production, producing over 30 batches for more than 200 patients.
  2. Multi-functional Imaging Probe for Cu(II)
    • Designed and synthesized Cu(II)-specific probes for fluorescence and 19F MR imaging.
    • Applied the 18F-isotopologue to PET imaging in cynomolgus macaques.
  3. Vasopressin 1a Receptor Targeted Tracer
    • Developed an F-18 labeled PET tracer with high affinity for V1a receptor.
    • Conducted PET imaging and kinetic modeling studies in rhesus monkeys.
  4. TSPO Polymorphism-insensitive PET Tracers
    • Synthesized ligands for TSPO, demonstrating low sensitivity to TSPO rs6971 polymorphism.
    • Conducted PET imaging studies in rhesus monkeys and MCAO animal models.
  5. 11C-labeled Tracers for mGlu2 and FAAH
    • Contributed to the development and analysis of 11C-labeled PET tracers for mGlu2 and FAAH.
  6. New Synthons and Radiolabeling Strategies
    • Synthesized [18F]difluorocarbene and [18F]fluoro-[di-deutero]methyl tosylate, implementing automated radiolabeling programs.
B. Development of Fluorescent Probes
  1. Eu(III) Complex as Fluorescent Probe for Paralytic Shellfish Toxins
    • Designed and characterized europium complexes, proposing binding mechanisms using ion mobility mass spectrometry.
  2. Fluorescent Chemosensors for Polyamines
    • Synthesized TPE-conjugated pentiptycene derivatives, applied for spermine detection in artificial urine.
  3. Fluorescent Probes and 1H/19F MRI Contrast Agents for EBNA1 and EBV
    • Designed and synthesized Eu(III) and Gd(III) complexes for EBNA1, evaluating magnetic resonance properties.
C. Organic Syntheses
  1. Total Synthesis of Natural Product (±)-basiliolide B and Its Analogues
    • Performed a 15-step synthesis sequence, including large-scale reactions.
  2. Regioselective Pd-catalyzed (3+2) Cycloaddition of 2-pyrones with Vinylcyclopropanes
    • Achieved high yields and regioselectivity, broadening substrate scope for synthesis.

Publications Top Noted:

Paper Title: A PET-based radiomics nomogram for individualized predictions of seizure outcomes after temporal lobe epilepsy surgery
  • Authors: Huanhua Wu, Kai Liao, Zhiqiang Tan, Chunyuan Zeng, Biao Wu, Ziqing Zhou, Hailing Zhou, Yongjin Tang, Jian Gong, Weijian Ye, Xueying Ling, Qiang Guo, Hao Xu
  • Journal: Seizure: European Journal of Epilepsy
  • Volume: 119
  • Pages: 17-27
  • Year: 2024
Paper Title: Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
  • Authors: Lingling Zhang, Kuan Hu, Tuo Shao, Lu Hou, Shaojuan Zhang, Weijian Ye, Lee Josephson, Jeffrey H Meyer, Ming-Rong Zhang, Neil Vasdev, Jinghao Wang, Hao Xu, Lu Wang, Steven H Liang
  • Journal: Acta Pharmaceutica Sinica B
  • Volume: 11
  • Pages: 373-393
  • Year: 2021
  • Citations: 114
Paper Title: Positron emission tomography in the neuroimaging of autism spectrum disorder: a review
  • Authors: Zhiqiang Tan, Huiyi Wei, Xiubao Song, Wangxiang Mai, Jiajian Yan, Weijian Ye, Xueying Ling, Lu Hou, Shaojuan Zhang, Sen Yan, Hao Xu, Lu Wang
  • Volume: 16
  • Pages: 806876
  • Year: 2022
  • Citations: 14
Paper Title: Sensitive and responsive pentiptycene-based molecular fluorescence chemosensor for detection of polyamines
  • Authors: Junrong Huang, Weijian Ye, Shuai Zha, Yezi Tao, Min Yang, Ke Huang, Jiqiang Liu, Yan-Ho Fung, Yang Li, Penghao Li, Lizhi Zhu, Chi-Sing Lee
  • Journal: Journal of Luminescence
  • Volume: 232
  • Pages: 117856
  • Year: 2021
  • Citations: 12
Paper Title: Recent developments on the application of molecular probes in multiple myeloma: Beyond [18F] FDG
  • Authors: Shaojuan Zhang, Jingjie Shang, Weijian Ye, Tianming Zhao, Hao Xu, Hui Zeng, Lu Wang
  • Volume: 10
  • Pages: 920882
  • Year: 2022
  • Citations: 1